Sign in

NCT06643273Recruiting

Evaluation of a Haptic Glove for Assessing Tactile Perception in Post-Stroke Patients

A Multicenter Randomized Controlled Trial on the Effects of Upper Limb Robotic Rehabilitation on Sensory and Cognitive Impairments in Subjects With Stroke. The SCORES (Sensory and Cognitive Outcomes of Robotic Exercises in Stroke) Study. Evaluation of a Haptic Glove.

Source: ClinicalTrials.gov · Last updated 24 Apr 2026

Brief summary (registry, in English)

The aim of the SCORES Haptic Glove Study is to assess the technical features, safety, and reliability of a sensor-equipped glove designed to evaluate tactile perception. This will help guide further technical and functional improvements to finalize the device. The secondary goal is to validate a new tactile sensitivity index based on data collected using the glove. This will be done in a randomized controlled multicenter study (ClinicalTrials.gov ID NCT06109324) aimed to compare the effectiveness of robotic upper limb rehabilitation to conventional treatment in improving cognitive and sensory deficits, as well as evaluating the impact of these deficits on motor recovery.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
126 (estimated)
First submitted
10 Oct 2024
Start date
4 Oct 2024
Primary completion date
30 Apr 2027
Lead sponsor
Fondazione Don Carlo Gnocchi ETS
Diseases
Stroke
NCT number
NCT06643273

What you commit to

  • Study type: Interventional
  • Planned participants: 126
  • From 4 Oct 2024 to the primary completion date, 30 Apr 2027
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • fixed contraction deformity in the affected limb that would interfere with active therapy (ankylosis, Modified Ashworth Scale = 4);

Other illness

  • behavioural and cognitive disorders and/or reduced compliance that would interfere with active therapy;

Other

  • severe deficits in visual acuity.

Who the study is looking for

  • a single event, verified by MRI or CT;
  • age between 18 and 85 years;
  • time since stroke within six months;
  • a demographically adjusted total score of the Montreal Cognitive Assessment (MoCA) between 15.5 and 22.23

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Fondazione Don Carlo Gnocchi
Coordinator of this site? Confirm its status
FlorenceItalyRecruiting
IRCCS Centro Neurolesi Bonino Pulejo
Coordinator of this site? Confirm its status
MessinaItalyRecruiting
Fondazione Don Carlo Gnocchi - Centro Santa Maria della Provvidenza
Coordinator of this site? Confirm its status
RomaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.